Fluconazole Therapeutic Cheat Sheet
Fluconazole is a synthetic triazole with a broader antifungal spectrum than the imidazole class. Resistance to first-pass metabolism and consistent oral absorption are advantages over agents like ketoconazole in the antifungal armamentarium, particularly in the context of the United States Food and Drug Administration’s reinforced warning against oral ketoconazole for skin and nail infections, d …
Fluconazole is a synthetic triazole with a broader antifungal spectrum than the imidazole class. Resistance to first-pass metabolism and consistent oral absorption are advantages over agents like ketoconazole in the antifungal armamentarium, particularly in the context of the United States Food and Drug Administration’s reinforced warning against oral ketoconazole for skin and nail infections, d … 
Welcome to the December 2023 issue of the Journal of Drugs in Dermatology (JDD), where cutting-edge research and advancements in the field of dermatology take center stage. This issue brings together a diverse array of original articles, case reports, brief communications, and letters to the editor and delves into the latest developments, therapeutic breakthroughs, and cl … 
Ruxolitinib (OPZELURA) is a twice daily topical cream that is FDA approved for non-segmental vitiligo and mild to moderate atopic dermatitis1. JAK inhibitors are a class of drugs effective in treating a wide variety of inflammatory conditions. Initially only FDA approved for non-dermatologic conditions such as rheumatoid arthritis and ulcerative colitis, there is now strong evidence that JAK/STAT … 
Following numerous office-based dermatologic procedures, erythema, swelling, and scarring are often feared complications experienced by our patients. Understanding the wound healing response is synonymous with understanding the stages of healing and ultimately the clinical appearance of each wound. Possessing and sharing a firm grasp on this knowledge allows for patient empowerment during the woun … 
The November 2023 issue of the Journal of Drugs in Dermatology (JDD) focuses on lasers, light sources, and devices featuring the perfect mix original articles, case reports, letters to the editor, and brief communications. Straight from the Editor’s desk, check out this month’s issue highlights.
ORIGINAL ARTICLES
Interventions to Minimize Pain During Photodynamic Therapy With 5-Aminolevulini … 